Spruce Biosciences wins Nasdaq appeal; must regain bid price compliance by Aug 5

SPRUCE BIOSCIENCES, INC.

Received Nasdaq delisting notice April 22, 2025; stock moved to OTC Pink on April 29, 2025.
On June 9, 2025, Nasdaq Hearings Panel accepted appeal; stock may resume on Nasdaq Capital Market if compliance met by August 5, 2025.
Panel retains jurisdiction until October 20, 2025; any future non-compliance must be reported to the panel.
Company seeks stockholder approval for reverse stock split (1:50 to 1:100) at July 22, 2025 annual meeting to cure bid price deficiency.

item 3.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.